» Articles » PMID: 38472252

Identification of Four Biotypes in Temporal Lobe Epilepsy Via Machine Learning on Brain Images

Overview
Journal Nat Commun
Specialty Biology
Date 2024 Mar 13
PMID 38472252
Authors
Affiliations
Soon will be listed here.
Abstract

Artificial intelligence provides an opportunity to try to redefine disease subtypes based on similar pathobiology. Using a machine-learning algorithm (Subtype and Stage Inference) with cross-sectional MRI from 296 individuals with focal epilepsy originating from the temporal lobe (TLE) and 91 healthy controls, we show phenotypic heterogeneity in the pathophysiological progression of TLE. This study was registered in the Chinese Clinical Trials Registry (number: ChiCTR2200062562). We identify two hippocampus-predominant phenotypes, characterized by atrophy beginning in the left or right hippocampus; a third cortex-predominant phenotype, characterized by hippocampus atrophy after the neocortex; and a fourth phenotype without atrophy but amygdala enlargement. These four subtypes are replicated in the independent validation cohort (109 individuals). These subtypes show differences in neuroanatomical signature, disease progression and epilepsy characteristics. Five-year follow-up observations of these individuals reveal differential seizure outcomes among subtypes, indicating that specific subtypes may benefit from temporal surgery or pharmacological treatment. These findings suggest a diverse pathobiological basis underlying focal epilepsy that potentially yields to stratification and prognostication - a necessary step for precise medicine.

Citing Articles

Temporal Lobe Epilepsy Perturbs the Brain-Wide Excitation-Inhibition Balance: Associations with Microcircuit Organization, Clinical Parameters, and Cognitive Dysfunction.

Xie K, Royer J, Rodriguez-Cruces R, Horwood L, Ngo A, Arafat T Adv Sci (Weinh). 2025; 12(9):e2406835.

PMID: 39806576 PMC: 11884548. DOI: 10.1002/advs.202406835.


Progressive brain atrophy and cortical reorganization related to surgery in temporal lobe epilepsy.

Li W, Qin Y, Li X, Zhang H, Gong Q, Zhou D Ann Clin Transl Neurol. 2024; 12(2):383-392.

PMID: 39708359 PMC: 11822803. DOI: 10.1002/acn3.52285.


Predicting the Path: How Machine Learning Can Identify Subtypes of Epilepsy and Predict Disease Progression.

Muldoon S Epilepsy Curr. 2024; 24(6):423-425.

PMID: 39540123 PMC: 11556290. DOI: 10.1177/15357597241279744.


Preclinical Testing Strategies for Epilepsy Therapy Development.

Riley V, Danzer S Epilepsy Curr. 2024; :15357597241292197.

PMID: 39539399 PMC: 11556302. DOI: 10.1177/15357597241292197.


Estimated Disease Progression Trajectory of White Matter Disruption in Unilateral Temporal Lobe Epilepsy: A Data-Driven Machine Learning Approach.

Sone D, Sato N, Shigemoto Y, Beheshti I, Kimura Y, Matsuda H Brain Sci. 2024; 14(10).

PMID: 39452006 PMC: 11506697. DOI: 10.3390/brainsci14100992.


References
1.
Coan A, Appenzeller S, Bonilha L, Li L, Cendes F . Seizure frequency and lateralization affect progression of atrophy in temporal lobe epilepsy. Neurology. 2009; 73(11):834-42. DOI: 10.1212/WNL.0b013e3181b783dd. View

2.
Lopez S, Aksman L, Oxtoby N, Vos S, Rao J, Kaestner E . Event-based modeling in temporal lobe epilepsy demonstrates progressive atrophy from cross-sectional data. Epilepsia. 2022; 63(8):2081-2095. PMC: 9540015. DOI: 10.1111/epi.17316. View

3.
Lamberink H, Otte W, Blumcke I, Braun K . Seizure outcome and use of antiepileptic drugs after epilepsy surgery according to histopathological diagnosis: a retrospective multicentre cohort study. Lancet Neurol. 2020; 19(9):748-757. DOI: 10.1016/S1474-4422(20)30220-9. View

4.
Jones A, Cascino G . Evidence on Use of Neuroimaging for Surgical Treatment of Temporal Lobe Epilepsy: A Systematic Review. JAMA Neurol. 2016; 73(4):464-70. DOI: 10.1001/jamaneurol.2015.4996. View

5.
Dalio M, Velasco T, Feitosa I, Assirati Junior J, Carlotti Junior C, Leite J . Long-Term Outcome of Temporal Lobe Epilepsy Surgery in 621 Patients With Hippocampal Sclerosis: Clinical and Surgical Prognostic Factors. Front Neurol. 2022; 13:833293. PMC: 9084624. DOI: 10.3389/fneur.2022.833293. View